Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits

We compile citations and summaries of about 400 new articles every week.

RSS Feed

HELP: Tutorials | FAQ

CONTACT US: Contact info

Search Results

Journal Article

Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits
Citation	Thong KY, Ryder RE, Cull ML, Walton C. Diabet. Med. 2012; 29(5): 690-692.
Copyright	(Copyright © 2012, Diabetes UK, Publisher John Wiley and Sons)
DOI	10.1111/j.1464-5491.2011.03475.x
PMID	21988449
Abstract	[Abstract unavailable] Language: en

NEW SEARCH
Download this record to:
RIS | BibTeX | EndNote

All SafetyLit records are available for automatic download to Zotero & Mendeley

Find full text at...